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In Western society obesity has become a
major health problem, and it is beginning to
replace undernutrition and infectious diseases
as the most signiﬁcant contributor to ill health
worldwide. Overweight individuals have a
strong predisposition to type 2 diabetes,
hyperlipidemia, hypercholesterolemia, and
hypertension (Kopelman 2000). We still do
not fully understand the multiple factors
involved in the etiology of diabetes and obe-
sity or how to prevent their development.
This is particularly unfortunate because these
conditions are treated by diet and exercice
with only mixed success. Dietary intervention
to control excess body weight, hyperglycemia,
and dyslipidemia have included low-energy
and low-fat diets but are of limited efficacy
and require strict and long-term commitment.
Therefore, new diet-based therapies to prevent
the occurrence of diabetes and obesity would
be very valuable.
Estrogens are major regulators of lipid
metabolism. They affect adipose tissue
directly by regulating lipogenesis, lipolysis, or
adipogenesis, or indirectly by modulating
appetite or energy expenditure [for review see
Cooke and Naaz (2004)]. In humans, estro-
gen insufﬁciency is responsible for the increase
in adiposity during menopause. Indeed, post-
menopausal women treated with estrogen
replacement therapies do not exhibit the
characteristic abdominal weight-gain pattern
associated with menopause (Gambacciani
et al. 1997). Similarly, the importance of
estrogens in lipid metabolism is highlighted
by the fact that individuals with mutations in
the aromatase gene exhibit truncal obesity,
insulin resistance, hypercholesterolemia, and
hypertriglyceridemia (Carani et al. 1997).
Further conﬁrmation of the role of estrogens
in regulating lipid metabolism has been
obtained in mice lacking estrogen receptor-α
(ER-α) or the aromatase gene: Both display
adipocyte hyperplasia and hypertrophy (Heine
et al. 2000; Jones et al. 2000). Recently, spe-
ciﬁc silencing of ER-α in the hypothalamus of
female rodents has been shown to lead to obe-
sity, hyperphagia, and reduced energy expendi-
ture, indicating that ER-α in hypothalamic
neurons plays an essential role in the control of
energy balance and the maintenance of normal
body weight (Musatov et al. 2007).
Phytoestrogens are nonsteroidal com-
pounds that can bind to both ER-α and ER-β
because of their ability to mimic the conforma-
tional structure of estradiol (Kuiper et al.
1997, 1998), and thereby imitate the actions
of estrogens on target tissues (Barnes 1998).
Phytoestrogens are found in many legumes
and are particularly abundant in soy products.
Genistin and daidzin, two major soy isoﬂavone
glucosides, are present at high concentrations
in soybeans and soybean-derived products and
are a major source of xenoestrogen exposure in
both humans (e.g., soy-based formula for
infants, tofu) and animals (most commercially
available diets). Certain Asian populations may
consume up to 1 mg/kg of body weight per
day, and infants fed soy-based formula ingest
even higher amounts of isoﬂavones on a per-
weight basis (Setchell et al. 1997). Multiple
studies in humans and animals suggest that,
similar to estrogens, dietary phytoestrogens
play a beneﬁcial role in reducing obesity and
improving glucose control [for review see
Bhathena and Velasquez (2002)]. Rodents fed
phytoestrogens have significantly decreased
adipose tissue compared with animals fed a
phytoestrogen-free diet (Lephart et al. 2004a),
and in humans, consumption of isoﬂavones is
associated with lower body mass index and
lower insulin levels (Goodman-Gruen and
Kritz-Silverstein 2001). Similarly, feeding mice
with pure dietary genistein at doses of
500–1,500 ppm has antilipogenic effects and
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BACKGROUND: Obesity is an increasingly prevalent health problem, and natural effective therapeu-
tic approaches are required to prevent its occurrence. Phytoestrogens are plant-derived compounds
with estrogenic activities; they can bind to both estrogen receptors α and β and mimic the action of
estrogens on target organs. 
OBJECTIVES: The purpose of this study was to examine the inﬂuence of soy-derived phytoestrogens
on energy balance and metabolism. 
METHODS: Male outbred mice (CD-1) were allowed ad libitum access to either a high soy-contain-
ing diet or a soy-free diet from conception to adulthood. We measured circulating serum isoﬂavone
levels using reverse-phase solid-phase extraction for subsequent liquid chromatography electrospray
tandem mass spectrometry analysis. Adult animals were analyzed for body composition by dual-
energy X-ray absorptiometry, locomotor activity by running-wheel experiments, respiratory
exchange rate by indirect calorimetry, and food intake using metabolic cages. Quantitative reverse
transcriptase-polymerase chain reaction was performed to determine the expression of hypothala-
mic neuropeptide genes. 
RESULTS: We found that adult mice fed a soy-rich diet had reduced body weight, adiposity, and
resistance to cold. This lean phenotype was associated with an increase in lipid oxidation due to a
preferential use of lipids as fuel source and an increase in locomotor activity. The modulation of
energy balance was associated with a central effect of phytoestrogens on the expression of hypothal-
amic neuropeptides, including agouti-related protein. 
CONCLUSION: The data suggest that dietary soy could have beneﬁcial effects on obesity, but they
also emphasize the importance of monitoring the phytoestrogen content of diets as a parameter of
variability in animal experiments. 
KEY WORDS: AgRP, endocrine disruptors, isoflavones, lipid oxidation, obesity, phytoestrogens.
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http://dx.doi.org/ [Online 12 July 2007]decreases adipose deposition (Naaz et al.
2003). However, the physiologic mechanisms
underlying the metabolic action of phytoestro-
gens on lipid metabolism and fat deposition
have not yet been determined. The purpose of
the present study was to characterize the inﬂu-
ence of dietary soy-derived phytoestrogens on
energy balance and adipose tissue. We show
here that mice exposed to phytoestrogens
maintain a lean phenotype associated with
hyperphagia, and have increased locomotor
activity, increased use of lipid as a fuel source,
and decreased resistance to cold. The modula-
tion of the energy balance is associated with
altered expression of hypothalamic peptides
involved in energy metabolism, including
agouti-related protein (AgRP).
Material and Methods
Diets. CD-1 mice were maintained on ad libi-
tum access to either a high soy–containing
[high phytoestrogen (HP)] diet (Harlan
Teklad 8604; Harlan Teklad, Madison, WI,
USA], or a soy-free [low phytoestrogen (LP)]
diet (Zeigler Phytoestrogen Reduced Rodent
Diet I; Zeigler Brothers, Gardner, PA, USA).
Weber et al. (2001) reported the isoflavone
content of these two closed-formula diets to
be approximately 150 ppm daidzein and
190 ppm genistein equivalents in the HP diet
and nondetectable in the LP diet. These con-
centrations of isoﬂavones are consistent with a
soy content of approximately 25% in the HP
diet. Both diets were equivalent in terms of
carbohydrate, protein, fat, amino acid, vita-
min, and mineral content (Weber et al. 2001).
In the LP diet formulation, soy was omitted
and replaced by lactic casein and dried skim
milk. The gross energy content (1,626 mJ/
100 g for the HP diet versus 1,668 mJ/100 g
for the LP diet), the metabolizable energy
(3,100 vs. 3,240 kcal/kg), and the digestable
energy (3,300 vs 3,530 kcal/kg) were similar
for both diets.
Animal care. CD-1 male and female mice
were purchased from Charles River (Arbresle,
France) for breeding. Animal protocols used
in these studies were approved by the
Commission d’Ethique de l’Expérimentation
Animale of the University of Geneva Medical
School and the Geneva Veterinarian Office.
Animals were treated humanely and with
regard for the alleviation of suffering. In short,
male and female mice used for breeding were
fed with the respective diets 6 weeks before
mating so that the offspring of the pairing
would be exposed solely to HP or LP diets.
Male and female mice used in this study were
therefore exposed to high or low levels of
isoflavones from conception onward, with a
broad window of exposure encompassing both
embryonic and postnatal development as well
as the adult period. Mice were housed in poly-
styrene instead of polycarbonate cages to avoid
potential contamination with bisphenol A, a
well-known endocrine-disrupting compound
with estrogenic activity.
Plasma phytoestrogen levels. The concen-
trations of total genistein, daidzein, and equol
were determined in individual plasma samples
collected at 0800 hours from adult male
mice (23–26 weeks of age) exposed through-
out life to HP (n = 12) or LP (n = 12) diets.
Enzymatically deconjugated plasma samples
were processed using reverse-phase solid-phase
extraction for subsequent liquid chromatogra-
phy electrospray tandem mass spectrometry
quantiﬁcation using isotope dilution in con-
junction with deuterium-labeled internal stan-
dards, as described previously by Twaddle
et al. (2002). Method accuracies were deter-
mined to be 86–102% for spiked blank serum
with relative SDs in the range of 0.5–3.3%.
Body composition determination by
DEXAscan. We used peripheral dual energy
X-ray absorptiometry (DEXA; PIXImus; GE-
Lunar Corp., Madison, WI, USA) to measure
the in vivo percentage of fat mass of male and
female mice. 
Food intake. We measured food intake in
3- and 6-month-old male mice (HP or LP)
housed individually in metabolic cages with
grid bottoms (3700M021; Indulab, Gams,
Switzerland). For habituation, animals were
maintained in metabolic cages for 48 consecu-
tive hours every week for 3 weeks. In the fourth
week, animals were transfered to metabolic
cages, accustomed during the ﬁrst day, and data
were then collected for the remaining 24 hr. 
Rotarod and open-ﬁeld test. Spontaneous
locomotor activity was assessed using an open-
ﬁeld test (45 cm × 45 cm) with an LE 8811
motor activity monitor (Bioseb, Chaville,
France). Male mice were tested for 10 min,
and activity was monitored automatically with
infrared beams. Data were recorded for each
mouse every minute, then analyzed and stored
using SeDaCom32 analyzer software (Bioseb). 
To assess physical motor coordination,
male mice were tested for their ability to stay
on an accelerating rotarod (accelerating model;
Ugo Basile, Comerio, Italy). After a 10-sec
habituation period on the stationary rod, the
mice were tested with the rod slowly accelerat-
ing at a constant pace from 4 to 40 rpm. The
rotation speed was increased every 30 sec by
4 rpm, with a maximum test duration of
5 min. Mice were scored on their latency to
fall from the rotating rod. Mice that fell
within the ﬁrst 10 sec were allowed one addi-
tional trial immediately after the ﬁrst. In these
few instances, the score from the second trial
was used in subsequent data analysis. The
tests were performed during two successive
days with three trials per day and an intertrial
interval of 20 min.
Blood and tissue chemistry. Blood was col-
lected by cardiac puncture from male mice
that had fasted 2 hr in the morning. Sera and
relevant peripheral tissues were stored at
–20°C and used subsequently to assess the
levels of metabolic hormones.
Histology. Tissues were fixed in Bouin’s
solution and embedded in paraffin. Sections
(5 µm) were stained with hematoxylin and
eosin (H&E). Images were captured and
analysis was performed with SigmaScan
(Jandel, San Rafael, CA, USA). We performed
morphometric analysis on adipose tissues by
measuring the surface of adipocytes in five
representative sections (~ 1,100 mm2 each) for
every HP and LP epididymal white adipose
tissue (WAT). The data were collected and
analyzed using the ImageJ software.
Locomotor activity. Male mice (24–27
weeks of age) were housed individually in
large plastic cages, each equipped with a run-
ning wheel, in ventilated, light-tight cabinets.
Each wheel revolution was registered by a
magnetic switch connected to a counter; the
number of revolutions was recorded every
minute for 8 consecutive days. The data were
measured and analyzed using Chronobiology
Kit computer software (Stanford Software
Systems, Santa Cruz, CA, USA). 
Indirect calorimetry. Whole-body oxygen
consumption rates, respiratory exchange rates,
and metabolic rates were measured by indirect
calorimetry using a four-chamber open-circuit
Oxymax system (Colombus Instruments,
Columbus, OH, USA). HP and LP male mice
(25–28 weeks of age) were housed individually
in plexiglas cages with an air ﬂow of 0.6 L/min
and a sample ﬂow of 0.5 L/min at 23°C. After
mice were given 2 days to adapt to the meta-
bolic chamber, we measured the volume of
oxygen consumed (VO2) and the volume of
carbon dioxide produced (VCO2) at 15-min
intervals for 48 hr. The metabolic rate (kilo-
calories per hour) was calculated from the fol-
lowing equation: (3.815 + 1.232 × RER) ×
VO2, where RER is the respiratory exchange
ratio (VCO2/VO2). 
Real-time RT-PCR (reverse transcriptase-
polymerase chain reaction). Total RNAs from
male hypothalamus were extracted using the
RNeasy mini kit (Qiagen, Hombrechtikon,
Switzerland) according to the manufacturer’s
protocols. RNA integrity and quantity were
assessed using RNA 6000 nanochips with an
Agilent 2100 bioanalyzer (Agilent Tech-
nologies, Palo Alto, CA, USA). One micro-
gram of total RNA was reverse-transcribed
with the Omniscript RT-kit (Qiagen) accord-
ing to manufacturer’s instructions. For each
PCR reaction, 1/20th of the cDNA template
was PCR ampliﬁed in a 7900HT SDS System
using Power SYBR Green PCR master mix
(both from Applied Biosystems, Foster City,
CA, USA). We obtained raw threshold-cycle
(Ct) values using SDS 2.0 software (Applied
Biosystems). Relative quantities (RQ) were
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efficiencies (E) calculated for each run with
the DART-PCR algorithm, as described by
Peirson et al. (2003). A mean quantity was
calculated from triplicate PCR reactions for
each sample, and this quantity was normalized
to the average of four endogenous control
genes (cyclophilin B, α2-tubulin, β-tubulin,
or β-actin) as described by Vandesompele
et al. (2002). Normalized quantities were aver-
aged for three replicates for each data point
and presented as the mean ± SD. We arbitrar-
ily designated the highest normalized relative
quantity as a value of 1.0. Fold changes were
calculated from the quotient of means of these
normalized quantities and reported as ± SE.
We determined the statistical significance of
fold changes by paired Student’s t-test. The
relevant primers used for PCR are listed in the
Supplemental Material (available online at
http://www.ehponline.org/members/2007/
10413/suppl.pdf).
Results
Exposure to dietary phytoestrogens. Male CD-1
mice were exposed to and fed either the HP
diet or the LP diet from conception to adult-
hood. Weber et al. (2001) reported the
isoﬂavone content of these two closed-formula
diets to be approximately 150 ppm daidzein
and 190 ppm genistein equivalents in the HP
diet and nondetectable in the LP diet. The lev-
els of isoflavones in plasma and diet were
directly correlated (Figure 1A); the average
steady-state plasma concentrations of genistein
(160 ± 79 ng/mL) and daidzein (150 ±
73 ng/mL) in mice consuming the HP diet
were well within the range observed in humans
consuming soy foods and nutritional supple-
ments (King and Bursill 1998; Setchell et al.
1997), whereas the daidzein metabolite equol
was present at higher concentrations (2,400 ±
290 ng/mL) than those observed in humans.
In contrast, the levels of plasma genistein,
daidzein, and equol were undetectable
(< 5 ng/mL) in mice fed the LP diet.
Reduced weight and adipose tissues in mice
exposed to phytoestrogens. Although body
weights were similar at weaning, a signiﬁcant
difference developed progressively in adults so
that at 4 months of age, male HP mice weighed
7.6% less than LP mice (Figure 1B). We found
a 2% reduction in body length (naso-anal dis-
tance) in adults (LP, 10.37 ± 0.08 cm; HP,
10.12 ± 0.06 cm; p < 0.05; n = 23 in each
group), suggesting that embryonic or postnatal
growth were slightly affected by dietary phyto-
estrogens. Overall fat content was markedly
lower in male HP mice (a 31% reduction at
4 months of age; Figure 1C), as determined by
DEXAscan (Figure 1E). Interestingly, in
females, reduction in weight (22%) and fat
content (36%) were more pronounced com-
pared with male HP mice (Figure 1D, E). 
Anatomical observations revealed a striking
difference in adipose tissue (Figure 1C). After
normalization to body weight, fat depots such
as the epididymal, inguinal, and peri-renal
WAT were reduced by > 50% (Figure 2A,B)
in contrast to other major organs such as liver
and spleen, which were not affected (data not
shown). We also observed a slight but signiﬁ-
cant increase in skeletal muscles and heart of
male but not female mice exposed to the HP
diet (Figure 2C,D). This increased muscular
mass may reﬂect the increased locomotor activ-
ity observed in HP mice. 
Sections of WAT showed decreased
adipocyte size in HP mice (Figure 2E); expo-
sure to phytoestrogens resulted in an average
2-fold reduction in the median cytoplasmic
area (Figure 2F,G) of WAT and a 5-fold
decrease in total triglyceride content
(Figure 2H). In contrast, total DNA content
was not altered (Figure 2H), indicating that
decreased fat mass is exclusively the result of
reduced fat storage in HP animals.
Reduced thermogenic activity in HP mice.
Adaptive thermogenesis might also be altered in
mice exposed to phytoestrogens. Interestingly,
we found the interscapular brown fat depot to
be 51% smaller in male mice fed the HP diet
compared with those fed the LP diet
(Figure 3A, n = 15 and 14, respectively;
p = 0.002). Histologic analysis indicated that
lipid droplets in HP brown adipocytes were
much smaller than those of LP brown
adipocytes (Figure 3B). Although the thermo-
genic capacity in mice depends on brown adi-
pose tissue (BAT) activity, the massive
reduction in BAT size and its lipid content in
HP mice did not affect body temperature in
normal conditions. At 20°C, HP and LP mice
had similar body temperature (Figure 3C). To
challenge the thermogenic capacity of these
animals, we exposed them to cold at 4°C for a
period of 4 hr. In the fed state, HP mice with-
stood the cold as well as the LP mice; however,
in the fasted state (Figure 3D), the body tem-
perature of HP mice fell much faster than that
of the LP mice, indicating that dietary phyto-
estrogens affect resistance to cold. To assess
how phytoestrogen exposure inﬂuences energy
metabolism in brown adipocytes, we deter-
mined the mRNA expression of genes involved
in lipid metabolism in BAT. We found that
the reduction in BAT weight in HP mice
was partially compensated by up-regulating
Leanness in mice exposed to dietary phytoestrogens
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Figure 1. Leanness in mice exposed to soy in the diet. (A) Serum isoﬂavone levels of adult male mice fed
HP or LP diet. (B,C) Body weight gain was signiﬁcantly reduced in HP male mice; bar = 1 cm. Total weight
(D) and fat content (E), as measured by DEXA analysis, were similar at weaning stage (postnatal day 21;
PND21) but were signiﬁcatively reduced in adult HP animals (PND120). Note that total weight and fat con-
tent were slightly more reduced in female than in male HP mice. Results are mean ± SE (n = 12/group,
except for morphologic analysis where n = 5/group). 
* p < 0.05, ** p < 0.01, and #p < 0.001 compared with control.
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# #uncoupling protein-1 (1.5-fold increase;
n = 8–9/group; p < 0.05; data not shown) and
down-regulating the lipogenic gene acetyl-CoA
carboxylase-1 (4.2-fold decrease; n = 8–9/
group; p < 0.05; data not shown), two impor-
tant genes regulating thermogenesis and lipid
oxidation. 
HP mice are hyperphagic and exhibit
increased metabolic rate, lipid utilization,
and locomotor activity. To determine
whether the lean phenotype of HP mice
could be a consequence of a difference in
their total energy balance, we first assessed
daily food intake using metabolic cages.
Surprisingly, male mice maintained on an HP
diet were hyperphagic, consuming 41% and
18% more food than LP-fed mice at 3 and
6 months of age, respectively (Figure 4A).
Total energy expenditure, which includes
physical activity, basal metabolism, and adap-
tive thermogenesis, should therefore also be
altered in HP mice. Indeed, mice exposed to
phytoestrogens exhibited a signiﬁcant increase
in metabolic rate (VO2; Figure 4B) and
energy expenditure (data not shown), as well
as a significant reduction in the RER
(Figure 4C) as measured by indirect calorime-
try. The RER reflects the ratio of carbohy-
drate to fatty acid oxidation; therefore, these
results are consistent with HP mice using a
greater ratio of lipids as a fuel source during
the resting phase. 
To assess whether differences in activity
levels may also be involved, we subjected LP
and HP mice to behavioral tests. Although
HP and LP mice were indistinguishable in
both rotarod and open ﬁeld activity tests (data
not shown), the nightly locomotor activity
(measured by the running wheel) of HP mice
was 45% higher (Figure 4D,E). As expected,
interleukin-6 mRNA, whose production in
skeletal muscle is markedly increased by exer-
cise, was up-regulated in tibialis skeletal muscle
of HP animals (2.03-fold increase by quantita-
tive RT-PCR; n = 8–9/group; p < 0.05; data
not shown). It remains possible that the
improved locomotor performance might have
been due to differences in body weight, but
we view this as unlikely because we found no
correlation between body weight and locomo-
tor performance within groups (data not
shown). Overall, increased energy expenditure
and locomotor activity, coupled with a
marked shift toward the use of lipids, must be
important contributing factors for the lean-
ness of HP mice. 
A central effect of phytoestrogens on the
expression of hypothalamic neuropeptides.
Estrogens are known to modulate locomotor
activity in rodents (Ogawa et al. 2003). The
increased locomotor activity of HP mice sug-
gests a direct central effect. Indeed, we found
that the abundance of AgRP gene transcripts
was down-regulated by 32%, whereas orexin
A, MCH (melanocortin hormone), and TRH
(thyroid-releasing hormone) mRNAs were up-
regulated by 40%, 25%, and 22%, respec-
tively, in the hypothalamus of HP animals
(Figure 4F). In contrast, NPY (neuropeptide
Y), POMC (proopiomelanocortin), and Cart
(cocaine and amphetamine regulated tran-
script) gene expression were not affected.
Increased production of orexin A and MCH,
which are both orexigenic peptides, may
explain the increased food intake observed in
HP mice. Consistent with our data, AgRP gene
expression has been shown to be repressed in
clonal NPY/AgRP hypothalamic neurons
exposed to 17β-estradiol (Titolo et al. 2006).
As we found to be the case for phytoestrogen-
exposed mice, aging AgRP-knockout animals
are lean because of increased metabolic rate,
lipid utilization, and locomotor activity
(Wortley et al. 2005). Available evidence sug-
gests that AgRP has central inhibitory action
on the hypothalamic–pituitary–thyroid axis by
suppressing hypothalamic TRH expression and
thereby decreasing circulating levels of thyroid
hormones (Fekete et al. 2002). Exposure to
phytoestrogens resulted in a slight but signiﬁ-
cant increase in levels of TRH mRNA,
although thyroid hormone levels (total T4 and
T3) and core body temperature did not appear
to be affected (data not shown). 
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Figure 2. Adiposity is drastically reduced in animals fed the HP diet. Abbreviations: WATe, epididymal WAT;
WATi, inguinal WAT; WATov, ovarian WAT; WATpr, peri-renal WAT. Fat mass (% of body weight) was less
pronounced in 5-month-old male HP mice (A) than in 4-month-old female mice (B). We also observed a signif-
icant increase of skeletal muscle mass in quadriceps (Quadri), gastrocnemius (Gastro), tibialis, and heart in
males (C) but not in females (D). (E). H&E staining of representative epididymal WAT sections of 5-month-old
HP (bottom) and LP (top) male mice; bar = 100 µm. The distribution (F) of cell size of LP (top) and HP (bottom)
male mice reveals a signiﬁcant reduction of the mean adipose cell surface (G). (H) Total triglyceride (TG) and
DNA in the WATe of HP males. Results are mean ± SE (n = 12/ group).
*p < 0.05, **p < 0.01, and #p < 0.001 compared with control. 
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For this study, we focused our attention on
the effects of a soy-rich diet containing high
levels of phytoestrogens instead of exposing
animals to pure isoﬂavones such as genistein
or diadzein. Although using pure unconju-
gated isoﬂavones represents a more controlled
experimental setup, using a soy-based diet
constitutes a more relevant model of phyto-
estrogen exposure for humans, cattle, and
rodents. Several data sets using different diet
formulations of varying isoﬂavone content have
shown that significant reductions in adipose
weight correlated with increasing doses of soy-
derived phytoestrogens (Lephart et al. 2004b).
Ruhlen et al. (Ruhlen RL, Howdeshell KL,
Mao J, Taylor JA, Bronson FH, Welshons
WV, vom Saal FS, unpublished data), who fol-
lowed a similar protocol of dietary soy exposi-
tion but used a different supplier, also observed
reduced adiposity in mice. Finally, dietary sup-
plementation with genistein has been reported
to reduce adipose tissue deposition in a dose-
dependent manner (Naaz et al. 2003; Penza
et al. 2006), indicating that genistein can have
pronounced antilipogenic effects and is proba-
bly the major soy constituent contributing to
this effect. 
Estrogens have been shown to influence
proliferation and differentiation of adipocyte
precursors during development (Anderson
et al. 2001). This suggests that phytoestrogens
could also influence adipocyte number. Our
results indicate that this is not the case: The
effects of dietary phytoestrogens reflect a
decrease in adipocyte size. These data are con-
sistent with previous work indicating that
genistein produces a dose-dependent decrease
in adipocyte size (Naaz et al. 2003). Two
important questions remain however. First, the
relative roles of ER-α and ER-β in mediating
the metabolic effects of dietary phytoestrogens
need to be ascertained, because both receptors
are expressed in adipocytes and hypothalamic
neurons (Kuiper et al. 1997; Pedersen et al.
2001). Second, their modes of action need to
be determined: Are phytoestrogens acting cen-
trally by modulating hypothalamic function
and/or directly by modulating lipogenesis
in adipocytes?
Central effects of dietary phytoestrogens.
Feeding behavior and locomotor activity were
modiﬁed by exposure to phytoestrogens, sug-
gesting that the hypothalamus, a region of the
brain playing a critical role in energy balance,
may be involved. The expression of genes
coding for the appetite-modifying peptides
MCH and orexin A was up-regulated in
hypothalami of HP mice. It is thus relevant to
note that in rodents, orexin A stimulates eat-
ing behavior and physical activity (Kotz et al.
2002), and intracerebroventricular adminis-
tration of MCH causes rapid increase in food
intake (Gomori et al. 2003). AgRP is another
critical regulator of energy balance that acts as
melanocortin receptor antagonist in hypothal-
amic regions controlling food intake and
energy expenditure (Stutz et al. 2005). The
signiﬁcant reduction of AgRP gene expression
levels together with the physiologic changes
associated with phytoestrogen exposure are
strikingly reminiscent of the phenotype of
animals lacking AgRP: AgRP mutant mice
display an age-related lean phenotype corre-
lated with increased metabolic rate, lipid uti-
lization, and locomotor activity (Wortley
et al. 2005). Similarly, a 50% inhibition of
AgRP expression in the hypothalamus using
RNA interference is also associated with
increased metabolic rate and reduced body
weight (Makimura et al. 2002). Both estrogen
receptors are present in the hypothalamic
nuclei and have been shown to modulate food
intake (Liang et al. 2002), locomotor activity
(Ogawa et al. 2003), and the expression of
orexigenic signals such as AgRP and NPY
(Titolo et al. 2006). Interestingly, the speciﬁc
silencing of ER-α in the ventromedial nucleus
of the hypothalamus in female rodents leads to
obesity and declines in energy expenditure,
voluntary activity, basal metabolic rate, and
thermogenesis (Musatov et al. 2007). Whether
these phenotypes are associated with changes
in the expression of hypothalamic neuro-
peptides remains unknown. Overall, these
findings indicate that dietary phytoestrogens
have a central action and may modulate
energy homeostasis in part by affecting the
expression of hypothalamic neuropeptides
such as orexin A, MCH, and AgRP. 
Phytoestrogens as a source of endocrine
disruptors in rodent diet. Our results empha-
size the importance of monitoring the phyto-
estrogen content of diets as a parameter of
variability in animal experiments. Research
laboratories should carefully select diets for
which the isoflavone content has been certi-
fied by the supplier. In almost all commer-
cially available diets, soy is used as a main
source of protein. The levels of conjugated
isoﬂavones contained in rodent diets are vari-
able and depend on the percentage of soy-
derived proteins within the commercial diet
itself and also in the individual batch of soy
protein that has been incorporated in the diet.
The variation in isoflavone content depends
on the type of soybean, the geographic area of
cultivation, and the harvest year. As a conse-
quence, different batches of an “identical”
commercial rodent diet may have variable lev-
els of isoﬂavones that could lead to inconsis-
tant results (vom Saal FS, Thigpen J, Setchell
KDR, Heindel J, unpublished data). The
effects of phytoestrogens on adipose tissue
and energy balance presented here should
strongly encourage research laboratories to
select diets for which the content in iso-
ﬂavones has been certiﬁed by the supplier.
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Figure 3. BAT weight and resistance to cold in male mice fed the HP or LP diets. Abbreviations: AF, after
fasting; BF, before fasting; RT, room temperature. BAT weight (A) and histology of 5-month-old LP and HP
mice (B; bar = 100 µm. Body temperature of adult HP and LP mice exposed 4°C for 4 hr BF (C) or AF 12 hr
(D). Results are mean ± SE. 
*p < 0.05, **p < 0.01, and #p < 0.001 compared with control. 
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HPThe most important issue however is
whether these results are relevant for humans.
Numerous studies suggest that soy-containing
food can have beneficial effects on diabetes
and obesity [for review see Usui (2006)]. For
example, isoflavone consumption reduces
human body mass indexes and insulin levels
(Goodman-Gruen and Kritz-Silverstein
2001). Comparisons between animal and
human studies are difficult because of varia-
tions in exposition protocols (e.g., route of
administration, composition, dose, duration)
and differences in intestinal bacterial metabo-
lism. Thus far, soy-derived phytoestrogens
have received prevalent usage because of their
benefits in decreasing age-related diseases
(e.g., osteoporosis, cardiovascular disease) and
hormone-dependent cancers (e.g., prostate
and breast cancer); however, as potent
endocrine disruptors, they can also pose
potential health risks. A legitimate area of
concern is dietary phytoestrogens used by
women at risk for breast cancer or those
already diagnosed with breast cancer.
Similarly, soy-based formula used as an alter-
native to breast milk or cow’s milk may
expose infants to estrogenic compounds at a
very vulnerable period for estrogenic insult
(West et al. 2005). Although critical ques-
tions remain in our understanding of the role
of soy and its component phytoestrogens in
the regulation of energy balance and obesity,
it is now clear that these compounds may
have more potent effects than originally
thought and that they may well represent an
effective natural approach to help prevent
some of the metabolic abnormalities that are
part of the metabolic syndrome.
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Figure 4. Food intake, lipid oxidation, and locomotor activity in male LP and HP mice. Abbreviations: FoxS1,
forkhead transcription factor; Phex, phosphate-regulating gene with homologies to endopeptidases on the
X chromosome. (A) Food intake measured at 3 and 6 months of age (n = 12/group). Metabolic rate (V02; B)
and RER in the resting period (C) determined by indirect calorimetry analysis. Locomotor activity was
higher in the ﬁrst part of the dark phase in adult HP mice compared with LP mice (n = 11–12/group) as rep-
resented by an actiogram (D) or as the average daily activity over a 24-hr period (E). Gene expression
determined by real-time quantitative PCR in hypothalami (F) is shown for each gene as percent of expres-
sion in HP mice relative to LP animals (n = 10/group). Results are mean ± SE.
*p < 0.05, **p < 0.01, and #p < 0.001 versus control. 
A 5
4
3
2
1
0
LP
**
F
o
o
d
 
i
n
t
a
k
e
 
(
g
)
HP
19 13
Time (hours)
20,000
15,000
10,000
5,000
V
O
2
 
(
m
L
/
k
g
/
h
r
)
B
C
HP LP
3 months 6 months
*
7 1
10,000
7,500
5,000
2,500
0
V
O
2
 
(
m
L
/
k
g
/
h
r
)
Night Day 24 hr
*
**
* #
**
19 13
Time (hours)
7 1
R
E
R
1.6
1.4
1.2
1.0
0.8
0.6
0.4
Night Day 24hr
1.00
0.75
0.50
0.25
R
E
R
#
# ****
30
20
10
0
19 17 21 23 1 3 5 7 9 11 13 15
Time (hours)
Night Day Total
8
6
4
2
0
D
i
s
t
a
n
c
e
 
(
k
m
)
M
e
a
n
 
t
o
u
r
s
 
p
e
r
 
m
i
n
u
t
e *
*
**
200
150
100
50
0
H
y
p
o
t
h
a
l
a
m
u
s
 
m
R
N
A
 
l
e
v
e
l
 
(
%
 
L
P
)
*
*
*
*
AgRP
FoxS1
Phex
NPY
POMC
Cart
MCH
TRH
Orexin A
D
E F
LP
HP
7 19 7 19 7
7 19 7 19 7
**
* *
LP
HPdecreases adipose deposition in mice. Endocrinology
144(8):3315–3320.
Ogawa S, Chan J, Gustafsson JA, Korach KS, Pfaff DW. 2003.
Estrogen increases locomotor activity in mice through
estrogen receptor alpha: speciﬁcity for the type of activity.
Endocrinology 144(1):230–239.
Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H,
Richelsen B. 2001. Demonstration of estrogen receptor sub-
types alpha and beta in human adipose tissue: inﬂuences of
adipose cell differentiation and fat depot localization. Mol
Cell Endocrinol 182(1):27–37.
Peirson SN, Butler JN, Foster RG. 2003. Experimental validation
of novel and conventional approaches to quantitative real-
time PCR data analysis. Nucleic Acids Res 31(14):e73.
Penza M, Montani C, Romani A, Vignolini P, Pampaloni B,
Tanini A, et al. 2006. Genistein affects adipose tissue deposi-
tion in a dose-dependent and gender-specific manner.
Endocrinology 147(12):5740–5751.
Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. 1997.
Exposure of infants to phyto-oestrogens from soy-based
infant formula. Lancet 350(9070):23–27.
Stutz AM, Morrison CD, Argyropoulos G. 2005. The Agouti-
related protein and its role in energy homeostasis. Peptides
26(10):1771–1781.
Titolo D, Cai F, Belsham DD. 2006. Coordinate regulation of
neuropeptide Y and agouti-related peptide gene expression
by estrogen depends on the ratio of estrogen receptor (ER)
α to ERβ in clonal hypothalamic neurons. Mol Endocrinol
20(9):2080–2092. 
Twaddle NC, Churchwell MI, Doerge DR. 2002. High-throughput
quantification of soy isoflavones in human and rodent
blood using liquid chromatography with electrospray mass
spectrometry and tandem mass spectrometry detection.
J Chromatogr B Analyt Technol Biomed Life Sci
777(1-2):139–145.
Usui T. 2006. Pharmaceutical prospects of phytoestrogens.
Endocr J 53(1):7-20.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N,
De Paepe A, et al. 2002. Accurate normalization of real-time
quantitative RT-PCR data by geometric averaging of multiple
internal control genes. Genome Biol 3(7): RESEARCH0034;
doi:10.1186/gb-2002-3-7-research0034 [Online 18 June 2002].
Weber KS, Setchell KD, Stocco DM, Lephart ED. 2001. Dietary
soy-phytoestrogens decrease testosterone levels and
prostate weight without altering LH, prostate 5alpha-reduc-
tase or testicular steroidogenic acute regulatory peptide
levels in adult male Sprague-Dawley rats. J Endocrinol
170(3):591–599.
West MC, Anderson L, McClure N, Lewis SE. 2005. Dietary
oestrogens and male fertility potential. Hum Fertil (Camb)
8(3):197–207.
Wortley KE, Anderson KD, Yasenchak J, Murphy A,
Valenzuela D, Diano S, et al. 2005. Agouti-related protein-
deﬁcient mice display an age-related lean phenotype. Cell
Metab 2(6):421–427.
Leanness in mice exposed to dietary phytoestrogens
Environmental Health Perspectives • VOLUME 115 | NUMBER 10 | October 2007 1473